A REVIEW ON RECENT ADVANCES IN COVID-19 MANAGEMENT
Sudhir Singh Gangwar*, Amita Tilak and Ranjana Sharma
ABSTRACT
The world has experienced several epidemics posing serious threat to
global public health, including the 2002 severe acute respiratory
syndrome (SARS) epidemic that caused 800 deaths out of about 8,000
cases, the 2009 H1N1 pandemic with 18,500 deaths, the 2012 Middle
East respiratory syndrome (MERS) epidemic that caused 800 deaths
out of 2,500 cases, the 2014 Ebola outbreak with 28,616 cases and
11,310 deaths, and the current coronavirus disease (COVID-19)
pandemic with more than 1,565,292 deaths out of over 68,659,920
confirmed cases till now. and is affecting 213 countries all over the
world. Coronavirus (CoV) disease-2019 (COVID-19) is an infectious
disease caused by the severe acute respiratory syndrome- CoV-2. The disease started in 2019
in Wuhan, China, and has spread globally, resulting in a pandemic. Common symptoms
include fever, cough, and shortness of breath. Muscle pain, sputum production, and sore
throat are less common symptoms. While the majority of cases result in mild symptoms,
some progress to pneumonia and multiorgan failure. The deaths per number of diagnosed
cases is estimated between 1% and 5%, on an average but varies by age and other health
conditions. The infection is spread from one person to other via respiratory droplets, often
produced during coughing and sneezing. It takes 2–14 days to develop symptoms from the
day of exposure. Reverse transcription- polymerase chain reaction from a nasopharyngeal
swab or oropharyngeal swab is the standard method of diagnosis. The infection can also be
diagnosed from a combination of symptoms, risk factors, and a computerized tomographic
scan of the chest showing features of viral pneumonia. Measures recommended to prevent the
disease include frequent hand washing, maintaining safe distance from other people, and not
touching one’s mouth eyes and nose. The use of masks is recommended for those who are
suspected to have the virus and to their caregivers, besides the general public. As of now,
there are currently more than 50 COVID-19 vaccine candidates in trials. WHO is working in collaboration with scientists, business, and global health organizations through the ACT Accelerator to speed up the pandemic response. Management of COVID-19 involves treatment of symptoms, supportive care, and experimental measures. In this review all relevant information about Corona virus management is given.
Keywords: Coronavirus; COVID-19; SARS-CoV-2; Infectious disease; Possible management.
[Full Text Article]